

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.13863279 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.13863279 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.41048742 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.05954080 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.05954080 |
| 6 | response to type I interferon (GO:0034340) | 4.67434309 |
| 7 | type I interferon signaling pathway (GO:0060337) | 4.64703701 |
| 8 | cellular response to type I interferon (GO:0071357) | 4.64703701 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51065707 |
| 10 | response to interferon-alpha (GO:0035455) | 4.25540375 |
| 11 | detection of other organism (GO:0098543) | 4.20789916 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.15329902 |
| 13 | surfactant homeostasis (GO:0043129) | 4.12921966 |
| 14 | response to interferon-beta (GO:0035456) | 4.02053099 |
| 15 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.95994817 |
| 16 | detection of molecule of bacterial origin (GO:0032490) | 3.76371703 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.74549287 |
| 18 | detection of external biotic stimulus (GO:0098581) | 3.73254691 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 3.59940316 |
| 20 | lymph vessel development (GO:0001945) | 3.59200420 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 3.58502956 |
| 22 | T cell migration (GO:0072678) | 3.54559816 |
| 23 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45613482 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 3.45368225 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.45108806 |
| 26 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.43035579 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 3.40940774 |
| 28 | cellular response to exogenous dsRNA (GO:0071360) | 3.32070858 |
| 29 | cellular response to interferon-beta (GO:0035458) | 3.30692147 |
| 30 | T-helper 1 type immune response (GO:0042088) | 3.29009934 |
| 31 | positive regulation of type 2 immune response (GO:0002830) | 3.28736881 |
| 32 | lymphocyte chemotaxis (GO:0048247) | 3.27569162 |
| 33 | regulation of RIG-I signaling pathway (GO:0039535) | 3.26826345 |
| 34 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.25447276 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.25006906 |
| 36 | negative regulation of viral genome replication (GO:0045071) | 3.24791532 |
| 37 | microglial cell activation (GO:0001774) | 3.23913076 |
| 38 | positive regulation of vasculogenesis (GO:2001214) | 3.21300353 |
| 39 | detection of biotic stimulus (GO:0009595) | 3.18966143 |
| 40 | B cell mediated immunity (GO:0019724) | 3.14736497 |
| 41 | positive regulation of tolerance induction (GO:0002645) | 3.11112300 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.10264951 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 3.10264951 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.10264951 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.10264951 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.10264951 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.10264951 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06320141 |
| 49 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.06272162 |
| 50 | chemical homeostasis within a tissue (GO:0048875) | 3.05749819 |
| 51 | cellular response to interferon-gamma (GO:0071346) | 3.05670724 |
| 52 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04401484 |
| 53 | dendritic cell chemotaxis (GO:0002407) | 3.04082511 |
| 54 | macrophage activation (GO:0042116) | 3.03222501 |
| 55 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.02995772 |
| 56 | response to host defenses (GO:0052200) | 3.00617485 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00617485 |
| 58 | response to host (GO:0075136) | 3.00617485 |
| 59 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.98865869 |
| 60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97882620 |
| 61 | regulation of vasculogenesis (GO:2001212) | 2.97778902 |
| 62 | response to interferon-gamma (GO:0034341) | 2.95269789 |
| 63 | regulation of type 2 immune response (GO:0002828) | 2.94646788 |
| 64 | interferon-gamma production (GO:0032609) | 2.92652889 |
| 65 | blood vessel maturation (GO:0001955) | 2.92359255 |
| 66 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.91240141 |
| 67 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89765899 |
| 68 | regulation of endothelial cell differentiation (GO:0045601) | 2.88694760 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 2.88235397 |
| 70 | dendritic cell migration (GO:0036336) | 2.87616787 |
| 71 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.87107403 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.86198794 |
| 73 | negative regulation of innate immune response (GO:0045824) | 2.86132902 |
| 74 | interferon-gamma secretion (GO:0072643) | 2.86093169 |
| 75 | neutrophil activation (GO:0042119) | 2.85138251 |
| 76 | regulation of T cell tolerance induction (GO:0002664) | 2.83692777 |
| 77 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.82566845 |
| 78 | negative regulation of type 2 immune response (GO:0002829) | 2.78902940 |
| 79 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.78033839 |
| 80 | endothelial tube morphogenesis (GO:0061154) | 2.77405938 |
| 81 | morphogenesis of an endothelium (GO:0003159) | 2.77405938 |
| 82 | cytidine deamination (GO:0009972) | 2.77292048 |
| 83 | cytidine metabolic process (GO:0046087) | 2.77292048 |
| 84 | cytidine catabolic process (GO:0006216) | 2.77292048 |
| 85 | endothelium development (GO:0003158) | 2.76598301 |
| 86 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.76447014 |
| 87 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.76149360 |
| 88 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.75799192 |
| 89 | regulation of regulatory T cell differentiation (GO:0045589) | 2.72551204 |
| 90 | response to protozoan (GO:0001562) | 2.71311586 |
| 91 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.70346811 |
| 92 | granulocyte activation (GO:0036230) | 2.70297723 |
| 93 | cellular response to interferon-alpha (GO:0035457) | 2.69529811 |
| 94 | defense response to protozoan (GO:0042832) | 2.69389373 |
| 95 | response to interleukin-15 (GO:0070672) | 2.68774240 |
| 96 | tolerance induction (GO:0002507) | 2.68024662 |
| 97 | defense response to virus (GO:0051607) | 2.66119184 |
| 98 | respiratory burst (GO:0045730) | 2.65293817 |
| 99 | positive regulation of defense response to virus by host (GO:0002230) | 2.64022397 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63946954 |
| 101 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.62096850 |
| 102 | regulation of immunoglobulin secretion (GO:0051023) | 2.60972467 |
| 103 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.60917453 |
| 104 | positive regulation of antigen processing and presentation (GO:0002579) | 2.55948853 |
| 105 | definitive hemopoiesis (GO:0060216) | 2.55902205 |
| 106 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.55298612 |
| 107 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.54921050 |
| 108 | regulation of response to interferon-gamma (GO:0060330) | 2.54104266 |
| 109 | positive regulation of humoral immune response (GO:0002922) | 2.53987222 |
| 110 | cellular response to virus (GO:0098586) | 2.53925664 |
| 111 | response to peptidoglycan (GO:0032494) | 2.53672963 |
| 112 | myeloid dendritic cell activation (GO:0001773) | 2.53035086 |
| 113 | negative T cell selection (GO:0043383) | 2.53005721 |
| 114 | cellular response to interleukin-15 (GO:0071350) | 2.52592341 |
| 115 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.48997087 |
| 116 | response to host immune response (GO:0052572) | 2.48579472 |
| 117 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.48579472 |
| 118 | negative thymic T cell selection (GO:0045060) | 2.45837455 |
| 119 | immunoglobulin mediated immune response (GO:0016064) | 2.44973007 |
| 120 | positive regulation of interferon-beta production (GO:0032728) | 2.43281279 |
| 121 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.43134250 |
| 122 | establishment of endothelial barrier (GO:0061028) | 2.42919049 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.41378867 |
| 124 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.40338826 |
| 125 | regulation of antigen processing and presentation (GO:0002577) | 2.40068248 |
| 126 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.39745825 |
| 127 | positive regulation of interleukin-17 production (GO:0032740) | 2.39530959 |
| 128 | regulation of natural killer cell differentiation (GO:0032823) | 2.38832418 |
| 129 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.38698166 |
| 130 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.38638222 |
| 131 | cellular extravasation (GO:0045123) | 2.38615061 |
| 132 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.38582745 |
| 133 | T-helper cell differentiation (GO:0042093) | 2.38582745 |
| 134 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.37505589 |
| 135 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.37245632 |
| 136 | detection of bacterium (GO:0016045) | 2.37070662 |
| 137 | leukocyte aggregation (GO:0070486) | 2.36253674 |
| 138 | response to muramyl dipeptide (GO:0032495) | 2.35926395 |
| 139 | regulation of tolerance induction (GO:0002643) | 2.35556419 |
| 140 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.34932268 |
| 141 | regulation of activation of Janus kinase activity (GO:0010533) | 2.34621663 |
| 142 | regulation of cellular extravasation (GO:0002691) | 2.34318934 |
| 143 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.33834327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.49174892 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.92758161 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.60282674 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.72177193 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.37838387 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 4.27707164 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.26151802 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.19560528 |
| 9 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.84692453 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79763217 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.77810041 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.77174674 |
| 13 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.74245881 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.56894051 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46944902 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.44912755 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41431899 |
| 18 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37827679 |
| 19 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.37167102 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.32370805 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17756753 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.16142627 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97269340 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96219810 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91133904 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89458091 |
| 27 | * MYB_26560356_Chip-Seq_TH2_Human | 1.87201577 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.85169120 |
| 29 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.80215375 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.78410750 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73014544 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72944851 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71539230 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67218554 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.66061524 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.57618491 |
| 37 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.57604386 |
| 38 | * MAF_26560356_Chip-Seq_TH1_Human | 1.48328337 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.48062730 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45757833 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42880074 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39552228 |
| 43 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.37961274 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31978938 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30827805 |
| 46 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28994353 |
| 47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28229866 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28175963 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28126891 |
| 50 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.25082475 |
| 51 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.22122662 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15136126 |
| 53 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13519370 |
| 54 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12826858 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11970420 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11805955 |
| 57 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.11516931 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11359714 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10328938 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09831064 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07301790 |
| 62 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06392765 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05015535 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04185482 |
| 65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03273606 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.02855386 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02233484 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01816835 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00147365 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97423369 |
| 71 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.97268396 |
| 72 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95761317 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95429395 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95326978 |
| 75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94942886 |
| 76 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90976785 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90105253 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90076377 |
| 79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89779882 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89570842 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88930438 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85959510 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85482658 |
| 84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84810265 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84639178 |
| 86 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84469417 |
| 87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84366661 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84067214 |
| 89 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.84001817 |
| 90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83797395 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83628671 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.83595788 |
| 93 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.83504499 |
| 94 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83086493 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82625742 |
| 96 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.82017242 |
| 97 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82004787 |
| 98 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81722964 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81265264 |
| 100 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80139375 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80024420 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79609855 |
| 103 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79602652 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77898623 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77548001 |
| 106 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.76712320 |
| 107 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75919030 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74886301 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.74773452 |
| 110 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.73702798 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73545099 |
| 112 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.73357997 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72738186 |
| 114 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.72661253 |
| 115 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72390532 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72306232 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 0.71026825 |
| 118 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70257314 |
| 119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.69440546 |
| 120 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.69208451 |
| 121 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69177401 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69006983 |
| 123 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68766849 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66880769 |
| 125 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.66788422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003724_increased_susceptibility_to | 3.63060402 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.33568778 |
| 3 | * MP0009785_altered_susceptibility_to | 3.17058880 |
| 4 | MP0010368_abnormal_lymphatic_system | 2.95641139 |
| 5 | MP0005671_abnormal_response_to | 2.91828047 |
| 6 | MP0005360_urolithiasis | 2.80163296 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 2.67297815 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.52531731 |
| 9 | MP0001790_abnormal_immune_system | 2.49316869 |
| 10 | MP0005387_immune_system_phenotype | 2.49316869 |
| 11 | MP0000685_abnormal_immune_system | 2.43726737 |
| 12 | * MP0005025_abnormal_response_to | 2.39942123 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.26505029 |
| 14 | MP0005167_abnormal_blood-brain_barrier | 2.13392174 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.12900034 |
| 16 | * MP0001800_abnormal_humoral_immune | 2.06856192 |
| 17 | MP0004782_abnormal_surfactant_physiolog | 2.06724671 |
| 18 | * MP0005000_abnormal_immune_tolerance | 2.00855313 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.00105068 |
| 20 | MP0004510_myositis | 1.99656968 |
| 21 | * MP0002723_abnormal_immune_serum | 1.97572425 |
| 22 | MP0006082_CNS_inflammation | 1.96942863 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.96648299 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.94239664 |
| 25 | MP0001853_heart_inflammation | 1.93372385 |
| 26 | MP0003436_decreased_susceptibility_to | 1.93127513 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.89801354 |
| 28 | MP0002419_abnormal_innate_immunity | 1.89690734 |
| 29 | MP0009764_decreased_sensitivity_to | 1.88495068 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.87971305 |
| 31 | * MP0002452_abnormal_antigen_presenting | 1.85165817 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.84475566 |
| 33 | MP0002006_tumorigenesis | 1.84436950 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.80244018 |
| 35 | * MP0001819_abnormal_immune_cell | 1.75289938 |
| 36 | MP0003828_pulmonary_edema | 1.74425227 |
| 37 | * MP0002420_abnormal_adaptive_immunity | 1.73745979 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.69519050 |
| 39 | MP0001873_stomach_inflammation | 1.61663266 |
| 40 | MP0008469_abnormal_protein_level | 1.60689959 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.59530537 |
| 42 | MP0004947_skin_inflammation | 1.50647375 |
| 43 | * MP0001845_abnormal_inflammatory_respons | 1.50159012 |
| 44 | MP0005166_decreased_susceptibility_to | 1.48612472 |
| 45 | MP0002405_respiratory_system_inflammati | 1.41744178 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.41164946 |
| 47 | * MP0000716_abnormal_immune_system | 1.40807841 |
| 48 | MP0003303_peritoneal_inflammation | 1.36837855 |
| 49 | MP0005365_abnormal_bile_salt | 1.36632070 |
| 50 | * MP0002398_abnormal_bone_marrow | 1.35462634 |
| 51 | MP0008260_abnormal_autophagy | 1.31986989 |
| 52 | MP0000343_altered_response_to | 1.30177975 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.29691489 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.28477113 |
| 55 | MP0003866_abnormal_defecation | 1.28460513 |
| 56 | MP0003195_calcinosis | 1.27853299 |
| 57 | MP0003075_altered_response_to | 1.27540356 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.26249791 |
| 59 | MP0005451_abnormal_body_composition | 1.23308148 |
| 60 | MP0003252_abnormal_bile_duct | 1.21309951 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.18045145 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.18045145 |
| 63 | MP0004883_abnormal_blood_vessel | 1.17903251 |
| 64 | MP0000249_abnormal_blood_vessel | 1.17636718 |
| 65 | * MP0002429_abnormal_blood_cell | 1.16316824 |
| 66 | * MP0001533_abnormal_skeleton_physiology | 1.13871486 |
| 67 | * MP0003448_altered_tumor_morphology | 1.13779843 |
| 68 | MP0002132_abnormal_respiratory_system | 1.13727960 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.13038819 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 1.12923470 |
| 71 | MP0009643_abnormal_urine_homeostasis | 1.11390335 |
| 72 | MP0004147_increased_porphyrin_level | 1.09510446 |
| 73 | MP0005165_increased_susceptibility_to | 1.08889202 |
| 74 | MP0009379_abnormal_foot_pigmentation | 1.08723236 |
| 75 | * MP0002722_abnormal_immune_system | 1.08706968 |
| 76 | * MP0009763_increased_sensitivity_to | 1.08265640 |
| 77 | MP0009840_abnormal_foam_cell | 1.06784683 |
| 78 | MP0003690_abnormal_glial_cell | 1.05433027 |
| 79 | MP0003172_abnormal_lysosome_physiology | 1.02096724 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 0.99054159 |
| 81 | MP0001663_abnormal_digestive_system | 0.98802182 |
| 82 | MP0001851_eye_inflammation | 0.98507849 |
| 83 | MP0010329_abnormal_lipoprotein_level | 0.97370111 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.97304521 |
| 85 | MP0009278_abnormal_bone_marrow | 0.94654762 |
| 86 | MP0005310_abnormal_salivary_gland | 0.94029898 |
| 87 | MP0001666_abnormal_nutrient_absorption | 0.89740440 |
| 88 | MP0000604_amyloidosis | 0.89594859 |
| 89 | MP0004272_abnormal_basement_membrane | 0.89488441 |
| 90 | MP0005408_hypopigmentation | 0.89356043 |
| 91 | MP0005164_abnormal_response_to | 0.88596586 |
| 92 | MP0010234_abnormal_vibrissa_follicle | 0.88449838 |
| 93 | MP0003943_abnormal_hepatobiliary_system | 0.87690971 |
| 94 | MP0003186_abnormal_redox_activity | 0.87658327 |
| 95 | MP0000767_abnormal_smooth_muscle | 0.86917538 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.86906782 |
| 97 | MP0004381_abnormal_hair_follicle | 0.86639845 |
| 98 | MP0003045_fibrosis | 0.86036354 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.85913554 |
| 100 | MP0001958_emphysema | 0.83957805 |
| 101 | * MP0000609_abnormal_liver_physiology | 0.83861554 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.81949459 |
| 103 | MP0001764_abnormal_homeostasis | 0.81027018 |
| 104 | MP0005332_abnormal_amino_acid | 0.80881112 |
| 105 | MP0009697_abnormal_copulation | 0.80665314 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.79516720 |
| 107 | MP0005409_darkened_coat_color | 0.79299696 |
| 108 | MP0004264_abnormal_extraembryonic_tissu | 0.79260694 |
| 109 | MP0004019_abnormal_vitamin_homeostasis | 0.78440016 |
| 110 | * MP0000703_abnormal_thymus_morphology | 0.77345516 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.76295990 |
| 112 | MP0006054_spinal_hemorrhage | 0.76057933 |
| 113 | MP0000858_altered_metastatic_potential | 0.75007422 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.74509897 |
| 115 | MP0002933_joint_inflammation | 0.74421146 |
| 116 | MP0008004_abnormal_stomach_pH | 0.73620151 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.70595771 |
| 118 | * MP0005390_skeleton_phenotype | 0.69472769 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.66466275 |
| 120 | MP0002876_abnormal_thyroid_physiology | 0.66181957 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64428003 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.63614616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous hematomas (HP:0007420) | 4.30034238 |
| 2 | Abnormality of the nasal mucosa (HP:0000433) | 3.92986846 |
| 3 | Chronic otitis media (HP:0000389) | 3.74260166 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.60348059 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.59962499 |
| 6 | Myositis (HP:0100614) | 3.54877873 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 3.43447330 |
| 8 | Polycythemia (HP:0001901) | 3.41694768 |
| 9 | Orchitis (HP:0100796) | 3.40933589 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.32421671 |
| 11 | Optic neuritis (HP:0100653) | 3.32421671 |
| 12 | Recurrent bronchitis (HP:0002837) | 3.25886752 |
| 13 | Esophageal varix (HP:0002040) | 3.21053529 |
| 14 | Hematochezia (HP:0002573) | 3.12193978 |
| 15 | Joint hemorrhage (HP:0005261) | 3.10459571 |
| 16 | Malnutrition (HP:0004395) | 3.09715046 |
| 17 | Increased IgM level (HP:0003496) | 3.07309071 |
| 18 | Prolonged bleeding time (HP:0003010) | 3.05737128 |
| 19 | Autoimmune hemolytic anemia (HP:0001890) | 3.01073012 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 2.96555958 |
| 21 | Recurrent abscess formation (HP:0002722) | 2.91184898 |
| 22 | Hemoptysis (HP:0002105) | 2.89355278 |
| 23 | Vasculitis (HP:0002633) | 2.87282458 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.86689869 |
| 25 | Abnormality of T cell number (HP:0011839) | 2.86518157 |
| 26 | Pulmonary embolism (HP:0002204) | 2.84357519 |
| 27 | Recurrent viral infections (HP:0004429) | 2.80428707 |
| 28 | Urticaria (HP:0001025) | 2.77037957 |
| 29 | Epistaxis (HP:0000421) | 2.76123079 |
| 30 | Gingival bleeding (HP:0000225) | 2.74576125 |
| 31 | T lymphocytopenia (HP:0005403) | 2.74217100 |
| 32 | Chest pain (HP:0100749) | 2.71840238 |
| 33 | Menorrhagia (HP:0000132) | 2.68625294 |
| 34 | Abnormality of macrophages (HP:0004311) | 2.67641419 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.66771141 |
| 36 | Nasal polyposis (HP:0100582) | 2.62437277 |
| 37 | Abnormality of T cells (HP:0002843) | 2.60925928 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.60079419 |
| 39 | Purpura (HP:0000979) | 2.59672745 |
| 40 | Hyperactive renin-angiotensin system (HP:0000841) | 2.59553565 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56928074 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56928074 |
| 43 | Peritonitis (HP:0002586) | 2.53081130 |
| 44 | Petechiae (HP:0000967) | 2.52805659 |
| 45 | Amyloidosis (HP:0011034) | 2.52684585 |
| 46 | IgM deficiency (HP:0002850) | 2.51823494 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 2.51267036 |
| 48 | Anorexia (HP:0002039) | 2.50559397 |
| 49 | Microcytic anemia (HP:0001935) | 2.47975569 |
| 50 | Abnormality of eosinophils (HP:0001879) | 2.45468353 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.44579448 |
| 52 | Cheilitis (HP:0100825) | 2.44376950 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.42240076 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.42052787 |
| 55 | Abnormality of the pleura (HP:0002103) | 2.41065678 |
| 56 | IgG deficiency (HP:0004315) | 2.41040077 |
| 57 | Pustule (HP:0200039) | 2.40812034 |
| 58 | Joint swelling (HP:0001386) | 2.39895538 |
| 59 | Eosinophilia (HP:0001880) | 2.38972852 |
| 60 | Meningitis (HP:0001287) | 2.38943889 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.38092587 |
| 62 | Encephalitis (HP:0002383) | 2.38009353 |
| 63 | Thrombophlebitis (HP:0004418) | 2.37193656 |
| 64 | Stomatitis (HP:0010280) | 2.37180283 |
| 65 | Recurrent skin infections (HP:0001581) | 2.34087262 |
| 66 | Granulocytopenia (HP:0001913) | 2.31840479 |
| 67 | Portal hypertension (HP:0001409) | 2.31719737 |
| 68 | Episodic fever (HP:0001954) | 2.28916626 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27958362 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.26760474 |
| 71 | Arterial thrombosis (HP:0004420) | 2.26244627 |
| 72 | Chronic sinusitis (HP:0011109) | 2.24501268 |
| 73 | Chronic diarrhea (HP:0002028) | 2.24315648 |
| 74 | Glomerulonephritis (HP:0000099) | 2.23599486 |
| 75 | Keratoconjunctivitis (HP:0001096) | 2.22777945 |
| 76 | Gangrene (HP:0100758) | 2.22555602 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.21705512 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.20307955 |
| 79 | IgA deficiency (HP:0002720) | 2.20060065 |
| 80 | Periodontitis (HP:0000704) | 2.19533120 |
| 81 | Severe combined immunodeficiency (HP:0004430) | 2.18918229 |
| 82 | Bronchitis (HP:0012387) | 2.17592281 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16642557 |
| 84 | Abnormal platelet function (HP:0011869) | 2.16406993 |
| 85 | Impaired platelet aggregation (HP:0003540) | 2.16406993 |
| 86 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.15731467 |
| 87 | Porencephaly (HP:0002132) | 2.15696990 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 2.14826572 |
| 89 | Basal ganglia calcification (HP:0002135) | 2.14374700 |
| 90 | Leukocytosis (HP:0001974) | 2.14150284 |
| 91 | Complement deficiency (HP:0004431) | 2.13387853 |
| 92 | Skin rash (HP:0000988) | 2.12761390 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 2.11574213 |
| 94 | Premature loss of primary teeth (HP:0006323) | 2.10438150 |
| 95 | Prolonged partial thromboplastin time (HP:0003645) | 2.10345494 |
| 96 | Abnormality of the hepatic vasculature (HP:0006707) | 2.09840224 |
| 97 | Pulmonary artery stenosis (HP:0004415) | 2.09513547 |
| 98 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08998259 |
| 99 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08998259 |
| 100 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08998259 |
| 101 | Hypochromic anemia (HP:0001931) | 2.08708341 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 2.08191299 |
| 103 | Acne (HP:0001061) | 2.07912024 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.07592972 |
| 105 | Colitis (HP:0002583) | 2.06809914 |
| 106 | Cellulitis (HP:0100658) | 2.05182694 |
| 107 | Conjugated hyperbilirubinemia (HP:0002908) | 2.05146860 |
| 108 | Abnormality of the endocardium (HP:0004306) | 2.04484692 |
| 109 | Osteomyelitis (HP:0002754) | 2.04174182 |
| 110 | Abnormality of complement system (HP:0005339) | 2.04077176 |
| 111 | Obstructive lung disease (HP:0006536) | 2.03570652 |
| 112 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03570652 |
| 113 | Loss of speech (HP:0002371) | 2.03351336 |
| 114 | Increased IgE level (HP:0003212) | 2.02527011 |
| 115 | Abnormal platelet volume (HP:0011876) | 2.02275198 |
| 116 | Panhypogammaglobulinemia (HP:0003139) | 2.01069762 |
| 117 | Conjunctival telangiectasia (HP:0000524) | 1.99526927 |
| 118 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.99482775 |
| 119 | Hypokalemic alkalosis (HP:0001949) | 1.98641918 |
| 120 | Pigmentary retinal degeneration (HP:0001146) | 1.96988619 |
| 121 | Agammaglobulinemia (HP:0004432) | 1.96166785 |
| 122 | Abnormality of the pericardium (HP:0001697) | 1.95540695 |
| 123 | Cerebral hemorrhage (HP:0001342) | 1.95063985 |
| 124 | Stomach cancer (HP:0012126) | 1.94718049 |
| 125 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.94606791 |
| 126 | Deep venous thrombosis (HP:0002625) | 1.94107842 |
| 127 | Skin ulcer (HP:0200042) | 1.93549635 |
| 128 | Thrombocytosis (HP:0001894) | 1.93295275 |
| 129 | Glomerulopathy (HP:0100820) | 1.91748288 |
| 130 | Combined immunodeficiency (HP:0005387) | 1.91659571 |
| 131 | Gingivitis (HP:0000230) | 1.90754308 |
| 132 | Thyroiditis (HP:0100646) | 1.90552492 |
| 133 | Hypoproteinemia (HP:0003075) | 1.90053623 |
| 134 | Vertigo (HP:0002321) | 1.89146604 |
| 135 | Acute hepatic failure (HP:0006554) | 1.88764307 |
| 136 | Alveolar cell carcinoma (HP:0006519) | 1.88648188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.35913608 |
| 2 | TXK | 3.90332073 |
| 3 | KDR | 3.81287810 |
| 4 | RIPK4 | 3.58287014 |
| 5 | TYK2 | 3.07045733 |
| 6 | MAP4K1 | 2.95214422 |
| 7 | IKBKE | 2.87782623 |
| 8 | FGFR4 | 2.76688172 |
| 9 | MAP3K14 | 2.66776615 |
| 10 | IRAK3 | 2.53152881 |
| 11 | JAK3 | 2.51586119 |
| 12 | TGFBR2 | 2.46052019 |
| 13 | KIT | 2.25396321 |
| 14 | TBK1 | 2.14504861 |
| 15 | JAK1 | 2.07688618 |
| 16 | IRAK4 | 1.98862350 |
| 17 | TEC | 1.87717136 |
| 18 | TAOK3 | 1.85436152 |
| 19 | FGFR3 | 1.75864336 |
| 20 | EPHB1 | 1.72955063 |
| 21 | ZAP70 | 1.60829503 |
| 22 | TGFBR1 | 1.56645700 |
| 23 | MST4 | 1.52738967 |
| 24 | NLK | 1.48515106 |
| 25 | FGR | 1.44386260 |
| 26 | IKBKB | 1.42373097 |
| 27 | CSK | 1.40959728 |
| 28 | PRPF4B | 1.36766111 |
| 29 | EPHA3 | 1.36678183 |
| 30 | IRAK1 | 1.33626725 |
| 31 | GRK1 | 1.31010921 |
| 32 | ACVR1B | 1.27904671 |
| 33 | NUAK1 | 1.26481072 |
| 34 | ITK | 1.25519151 |
| 35 | LMTK2 | 1.22737994 |
| 36 | BLK | 1.19962036 |
| 37 | STK10 | 1.18986427 |
| 38 | BTK | 1.15636177 |
| 39 | MAP3K1 | 1.11944841 |
| 40 | LCK | 1.09181606 |
| 41 | MYLK | 1.08784481 |
| 42 | MAP3K2 | 1.07696975 |
| 43 | TAOK1 | 1.06602467 |
| 44 | NEK9 | 1.03864397 |
| 45 | SIK3 | 0.97158108 |
| 46 | INSRR | 0.96603337 |
| 47 | NME2 | 0.94959589 |
| 48 | CHUK | 0.93710815 |
| 49 | JAK2 | 0.89614094 |
| 50 | MAP3K11 | 0.87355541 |
| 51 | STK16 | 0.86748311 |
| 52 | HCK | 0.84161284 |
| 53 | SYK | 0.83856200 |
| 54 | FRK | 0.82904061 |
| 55 | MAP2K3 | 0.81399024 |
| 56 | FES | 0.79618863 |
| 57 | CDC42BPA | 0.79571016 |
| 58 | ERN1 | 0.78570042 |
| 59 | PIM1 | 0.74439212 |
| 60 | HIPK2 | 0.73034461 |
| 61 | PIM2 | 0.70564361 |
| 62 | PDK1 | 0.70279755 |
| 63 | LYN | 0.70202648 |
| 64 | PRKG2 | 0.70126378 |
| 65 | PBK | 0.67869468 |
| 66 | GRK7 | 0.67854207 |
| 67 | PRKCQ | 0.67807930 |
| 68 | MAPK15 | 0.67252412 |
| 69 | MAP3K6 | 0.66107379 |
| 70 | PIK3CG | 0.65494039 |
| 71 | EIF2AK2 | 0.64681877 |
| 72 | MAP3K12 | 0.64608663 |
| 73 | ADRBK2 | 0.61454926 |
| 74 | KSR2 | 0.60440507 |
| 75 | FER | 0.60164944 |
| 76 | PDPK1 | 0.60022273 |
| 77 | LRRK2 | 0.59708440 |
| 78 | BCKDK | 0.58196242 |
| 79 | PTK6 | 0.57481741 |
| 80 | MATK | 0.56693647 |
| 81 | MAPK11 | 0.55493910 |
| 82 | MARK3 | 0.54771475 |
| 83 | STK4 | 0.54634895 |
| 84 | PRKAA2 | 0.54088329 |
| 85 | MAPK7 | 0.53295797 |
| 86 | TESK2 | 0.53095127 |
| 87 | IRAK2 | 0.53090342 |
| 88 | FYN | 0.52807350 |
| 89 | RPS6KA4 | 0.51659557 |
| 90 | MUSK | 0.51627299 |
| 91 | PRKD2 | 0.48621544 |
| 92 | RIPK1 | 0.48318609 |
| 93 | MAP2K6 | 0.47345099 |
| 94 | YES1 | 0.47321975 |
| 95 | BMPR1B | 0.45494493 |
| 96 | EPHB2 | 0.45065008 |
| 97 | ZAK | 0.44623232 |
| 98 | BMPR2 | 0.44086199 |
| 99 | MAPK4 | 0.43872138 |
| 100 | RET | 0.43253923 |
| 101 | PTK2B | 0.42987953 |
| 102 | CDK9 | 0.42879639 |
| 103 | MAP3K13 | 0.41320006 |
| 104 | STK24 | 0.41223180 |
| 105 | IGF1R | 0.40910877 |
| 106 | MAP3K7 | 0.40667007 |
| 107 | TNK2 | 0.40513920 |
| 108 | GRK6 | 0.40127172 |
| 109 | OXSR1 | 0.39861114 |
| 110 | MAP3K5 | 0.38879674 |
| 111 | ABL1 | 0.38678166 |
| 112 | MAPKAPK2 | 0.37258965 |
| 113 | CSF1R | 0.36927494 |
| 114 | TRPM7 | 0.36917627 |
| 115 | TNIK | 0.36911467 |
| 116 | FLT3 | 0.36575042 |
| 117 | MARK2 | 0.36217111 |
| 118 | CLK1 | 0.36160770 |
| 119 | MST1R | 0.36073933 |
| 120 | MAP3K3 | 0.34761499 |
| 121 | TAOK2 | 0.31938046 |
| 122 | CDK6 | 0.31789742 |
| 123 | STK38 | 0.31317176 |
| 124 | EGFR | 0.30326379 |
| 125 | DAPK2 | 0.28869703 |
| 126 | PRKCD | 0.28174857 |
| 127 | CDK4 | 0.27994050 |
| 128 | PIK3CA | 0.27083118 |
| 129 | RPS6KA5 | 0.26698458 |
| 130 | CAMKK2 | 0.26274317 |
| 131 | WNK4 | 0.24626988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.01912464 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.95977178 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.88460026 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.81549997 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.74316335 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.61563898 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.49863359 |
| 8 | * Measles_Homo sapiens_hsa05162 | 2.33232900 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.32613128 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.32416136 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.21893087 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.10648979 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.00392938 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95722233 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94206865 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.91002574 |
| 17 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.72067224 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.70054557 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.69220672 |
| 20 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.68469085 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.58987199 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54018355 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.53564500 |
| 24 | * Influenza A_Homo sapiens_hsa05164 | 1.52347398 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.51602190 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.50650252 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47649945 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43381529 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39157698 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36152434 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33802203 |
| 32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.31916318 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31621207 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31012254 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.25944335 |
| 36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.25468809 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.24749579 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20973616 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.18810238 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10593989 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.09871454 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08508007 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.04879612 |
| 44 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04438106 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01799490 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.01265306 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00969489 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99308009 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.98666697 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98133028 |
| 51 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.97219479 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89585033 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85219659 |
| 54 | Ribosome_Homo sapiens_hsa03010 | 0.79567023 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79534061 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76496281 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76431267 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76325745 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75364231 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.75073287 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75003424 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74693843 |
| 63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74006684 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73717887 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.73287624 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72909010 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72184175 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71581346 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.67751074 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66732020 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.66682868 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66505409 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66347543 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64620604 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.60685638 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60619224 |
| 77 | * Apoptosis_Homo sapiens_hsa04210 | 0.60427071 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60226773 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57886491 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57077731 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56694226 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.54687711 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54298216 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53894863 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52540943 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52163738 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51582035 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51424155 |
| 89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50809070 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.50226659 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49965348 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.48380451 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47740597 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.46719025 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.46187602 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45776445 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44371264 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42254268 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42223520 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41946492 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.41701368 |
| 102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40810353 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40515352 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39055290 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38106989 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36237549 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35868342 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34910846 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34307528 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34132057 |
| 111 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.33418424 |
| 112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33085580 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.32564744 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31893783 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31012355 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30555392 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.30513867 |
| 118 | Lysine degradation_Homo sapiens_hsa00310 | 0.30231473 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30094712 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29498226 |

